NPORT-EX 2 VIRGE50VirtusSilSmCpGrthStFd.htm
Silvant Small-Cap Growth Stock Fund
SCHEDULE OF INVESTMENTS (Unaudited)
March 31, 2020
($ reported in thousands)
  Shares   Value
Common Stocks—96.2%
Communication Services—3.9%    
Cable One, Inc. 231   $380
Cardlytics, Inc.(1) 6,196   216
Roku, Inc.(1) 3,279   287
      883
       
 
Consumer Discretionary—8.2%    
Boot Barn Holdings, Inc.(1) 4,758   61
Cavco Industries, Inc.(1) 948   137
Churchill Downs, Inc. 2,700   278
Five Below, Inc.(1) 2,702   190
Ollie’s Bargain Outlet Holdings, Inc.(1) 3,378   157
Planet Fitness, Inc. Class A(1) 4,492   219
Shake Shack, Inc. Class A(1) 1,601   60
Texas Roadhouse, Inc. 9,290   384
Wingstop, Inc. 4,713   376
      1,862
       
 
Consumer Staples—3.2%    
Boston Beer Co., Inc. (The) Class A(1) 530   195
J&J Snack Foods Corp. 1,376   167
WD-40 Co. 1,859   373
      735
       
 
Financials—6.6%    
Ameris Bancorp 6,270   149
Ares Management Corp. Class A 7,623   236
Essent Group Ltd. 3,238   85
First Financial Bankshares, Inc. 11,722   315
FirstCash, Inc. 1,678   120
Goosehead Insurance, Inc. Class A(1) 3,777   169
NMI Holdings, Inc. Class A(1) 6,766   78
RLI Corp. 3,834   337
      1,489
       
 
Health Care—32.1%    
Addus HomeCare Corp.(1) 1,297   88
Aimmune Therapeutics, Inc.(1) 7,619   110
Allakos, Inc.(1) 2,242   100
Amedisys, Inc.(1) 866   159
Bio-Techne Corp. 2,301   436
Chemed Corp. 1,589   688
Encompass Health Corp. 8,195   525
GW Pharmaceuticals plc ADR(1) 2,095   183
  Shares   Value
       
Health Care—continued    
HealthEquity, Inc.(1) 6,644   $336
Insmed, Inc.(1) 5,270   84
Inspire Medical Systems, Inc.(1) 4,324   261
Insulet Corp.(1) 4,201   696
LHC Group, Inc.(1) 3,409   478
Madrigal Pharmaceuticals, Inc.(1) 1,291   86
Natera, Inc.(1) 9,493   283
Novocure Ltd.(1) 5,536   373
Penumbra, Inc.(1) 2,758   445
Phreesia, Inc.(1) 10,231   215
Reata Pharmaceuticals, Inc. Class A(1) 3,483   503
REGENXBIO, Inc.(1) 3,971   129
Sarepta Therapeutics, Inc.(1) 4,393   430
Tandem Diabetes Care, Inc.(1) 7,307   470
Ultragenyx Pharmaceutical, Inc.(1) 4,570   203
      7,281
       
 
Industrials—19.1%    
ASGN, Inc.(1) 4,676   165
Barnes Group, Inc. 3,764   157
Brink’s Co. (The) 5,465   285
BWX Technologies, Inc. 3,626   177
Casella Waste Systems, Inc. Class A(1) 11,066   432
Chart Industries, Inc.(1) 5,212   151
ESCO Technologies, Inc. 2,104   160
Herc Holdings, Inc.(1) 3,226   66
IAA, Inc.(1) 2,525   76
Kratos Defense & Security Solutions, Inc.(1) 14,832   205
Mercury Systems, Inc.(1) 7,788   556
MSA Safety, Inc. 2,366   239
Parsons Corp.(1) 2,539   81
Proto Labs, Inc.(1) 2,883   220
Saia, Inc.(1) 4,501   331
Simpson Manufacturing Co., Inc. 3,603   223
Teledyne Technologies, Inc.(1) 2,687   799
      4,323
       
 
Information Technology—18.5%    
Brooks Automation, Inc. 5,516   168
Cabot Microelectronics Corp. 2,756   315
Coupa Software, Inc.(1) 3,351   468
Everbridge, Inc.(1) 4,521   481
  Shares   Value
       
Information Technology—continued    
Five9, Inc.(1) 9,094   $695
Mimecast Ltd.(1) 5,348   189
Paycom Software, Inc.(1) 880   178
Proofpoint, Inc.(1) 2,416   248
PROS Holdings, Inc.(1) 3,959   123
Q2 Holdings, Inc.(1) 13,572   801
Tower Semiconductor Ltd.(1) 10,401   166
Varonis Systems, Inc.(1) 1,772   113
ViaSat, Inc.(1) 6,891   247
      4,192
       
 
Materials—4.6%    
Ashland Global Holdings, Inc. 2,663   133
Balchem Corp. 5,551   548
Quaker Chemical Corp. 1,647   208
W.R. Grace & Co. 4,143   148
      1,037
       
 
Total Common Stocks
(Identified Cost $19,188)
  21,802
       
 
       
 
Total Long-Term Investments—96.2%
(Identified Cost $19,188)
  21,802
       
 
       
 
Short-Term Investment—1.6%
Money Market Mutual Fund—1.6%
Dreyfus Government Cash Management Fund - Institutional Shares (seven-day effective yield 0.290%)(2) 363,267   363
Total Short-Term Investment
(Identified Cost $363)
  363
       
 
       
 
TOTAL INVESTMENTS—97.8%
(Identified Cost $19,551)
  $22,165
Other assets and liabilities, net—2.2%   509
NET ASSETS—100.0%   $22,674
    
Abbreviation:
ADR American Depositary Receipt
    
Footnote Legend:
(1) Non-income producing.
(2) Shares of this fund are publicly offered, and its prospectus and annual report are publicly available.
See Notes to Schedule of Investments
1

Silvant Small-Cap Growth Stock Fund
SCHEDULE OF INVESTMENTS (Unaudited) (Continued)
March 31, 2020
($ reported in thousands)
The following table summarizes the market value of the Fund’s investments as of March 31, 2020, based on the inputs used to value them (See Security Valuation Note 1 in the Notes to Schedule of Investments):
  Total
Value at
March 31, 2020
  Level 1
Quoted Prices
Assets:      
Equity Securities:      
Common Stocks $21,802   $21,802
Money Market Mutual Fund 363   363
Total Investments $22,165   $22,165
There were no securities valued using significant observable inputs (Level 2) or significant unobservable inputs (Level 3) at March 31, 2020.
There were no transfers into or out of Level 3 related to securities held at March 31, 2020.
See Notes to Schedule of Investments
2

SILVANT SMALL-CAP GROWTH STOCK FUND
NOTES TO SCHEDULE OF INVESTMENTS (Unaudited)
March 31, 2020
Note 1. Security Valuation
The Fund utilizes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The Fund’s policy is to recognize transfers into or out of Level 3 at the end of the reporting period.
Level 1 – quoted prices in active markets for identical securities (security types generally include listed equities).
Level 2 – prices determined using other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
Level 3 – prices determined using significant unobservable inputs (including the Valuation Committee’s own assumptions in determining the fair value of investments).
A description of the valuation techniques applied to the Fund’s major categories of assets and liabilities measured at fair value on a recurring basis is as follows:
Equity securities are valued at the official closing price (typically last sale) on the exchange on which the securities are primarily traded or, if no closing price is available, at the last bid price and are categorized as Level 1 in the hierarchy. Restricted equity securities and private placements that are illiquid, or are internally fair valued by the Valuation Committee, are generally categorized as Level 3 in the hierarchy.
Certain non-U.S. securities may be fair valued in cases where closing prices are not readily available or are deemed not reflective of readily available market prices. For example, significant events (such as movement in the U.S. securities market, or other regional and local developments) may occur between the time that non-U.S. markets close (where the security is principally traded) and the time that the Fund calculates its net asset value (“NAV”) at the close of regular trading on the New York Stock Exchange (“NYSE”) (generally 4 p.m. Eastern time) that may impact the value of securities traded in these non-U.S. markets. In such cases, the Fund fair values non-U.S. securities using an independent pricing service which considers the correlation of the trading patterns of the non-U.S. security to the intraday trading in the U.S. markets for investments such as American Depositary Receipts, financial futures, exchange-traded funds (“ETFs”), and certain indexes, as well as prices for similar securities. Such fair valuations are categorized as Level 2 in the hierarchy. Because the frequency of significant events is not predictable, fair valuation of certain non-U.S. common stocks may occur on a frequent basis.
Listed derivatives, such as options, that are actively traded are valued based on quoted prices from the exchange and are categorized as Level 1 in the hierarchy. Over-the-counter derivative contracts, which include forward currency contracts and equity-linked instruments, do not require material subjectivity as pricing inputs are observed from actively quoted markets and are categorized as Level 2 in the hierarchy.
Investments in open-end mutual funds are valued at NAV. Investments in closed-end funds and ETFs are valued as of the close of regular trading on the NYSE each business day. Each is categorized as Level 1 in the hierarchy.
A summary of the inputs used to value the Fund’s net assets by each major security type is disclosed at the end of the Schedule of Investments for the Fund. The inputs or methodologies used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
For additional information about significant accounting policies, refer to the Fund’s most recent semi or annual report.
3